Biodexa Non Current Assets Total vs Intangible Assets Analysis

BDRX Stock   4.57  0.17  3.86%   
Biodexa Pharmaceticals financial indicator trend analysis is way more than just evaluating Biodexa Pharmaceticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biodexa Pharmaceticals is a good investment. Please check the relationship between Biodexa Pharmaceticals Non Current Assets Total and its Intangible Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodexa Pharmaceticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Biodexa Stock please use our How to Invest in Biodexa Pharmaceticals guide.

Non Current Assets Total vs Intangible Assets

Non Current Assets Total vs Intangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biodexa Pharmaceticals Non Current Assets Total account and Intangible Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Biodexa Pharmaceticals' Non Current Assets Total and Intangible Assets is 0.98. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Biodexa Pharmaceticals, assuming nothing else is changed. The correlation between historical values of Biodexa Pharmaceticals' Non Current Assets Total and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Biodexa Pharmaceticals are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Non Current Assets Total i.e., Biodexa Pharmaceticals' Non Current Assets Total and Intangible Assets go up and down completely randomly.

Correlation Coefficient

0.98
Relationship DirectionPositive 
Relationship StrengthVery Strong

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.
Most indicators from Biodexa Pharmaceticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biodexa Pharmaceticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodexa Pharmaceticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Biodexa Stock please use our How to Invest in Biodexa Pharmaceticals guide.At this time, Biodexa Pharmaceticals' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 0.62 in 2024, whereas Selling General Administrative is likely to drop slightly above 3.9 M in 2024.

Biodexa Pharmaceticals fundamental ratios Correlations

0.360.670.980.81-0.730.10.670.820.950.56-0.240.820.620.620.010.710.890.940.220.66-0.38-0.250.39-0.29-0.22
0.360.790.220.19-0.050.160.120.030.45-0.24-0.240.030.310.06-0.250.640.080.410.060.650.090.110.2-0.060.21
0.670.790.560.63-0.210.270.670.290.790.31-0.340.290.670.49-0.230.920.370.710.440.760.05-0.220.45-0.27-0.17
0.980.220.560.82-0.80.090.620.860.910.55-0.250.860.540.610.060.590.920.90.150.59-0.43-0.30.38-0.27-0.28
0.810.190.630.82-0.40.170.790.520.870.68-0.380.520.610.85-0.030.660.620.790.490.6-0.23-0.470.59-0.39-0.49
-0.73-0.05-0.21-0.8-0.4-0.04-0.29-0.97-0.52-0.240.06-0.97-0.15-0.11-0.09-0.2-0.94-0.550.16-0.240.40.14-0.130.080.07
0.10.160.270.090.17-0.040.10.030.190.09-0.920.030.380.31-0.960.330.020.180.470.00.83-0.690.72-0.69-0.69
0.670.120.670.620.79-0.290.10.450.710.82-0.090.450.690.680.010.730.520.640.620.42-0.12-0.350.39-0.35-0.36
0.820.030.290.860.52-0.970.030.450.610.42-0.061.00.290.240.110.320.990.630.030.35-0.42-0.170.2-0.14-0.11
0.950.450.790.910.87-0.520.190.710.610.57-0.360.610.740.76-0.080.830.70.980.310.7-0.27-0.330.48-0.35-0.33
0.56-0.240.310.550.68-0.240.090.820.420.57-0.090.420.590.770.010.470.470.560.570.16-0.14-0.360.23-0.43-0.37
-0.24-0.24-0.34-0.25-0.380.06-0.92-0.09-0.06-0.36-0.09-0.06-0.39-0.480.86-0.37-0.09-0.33-0.43-0.22-0.660.71-0.790.680.73
0.820.030.290.860.52-0.970.030.451.00.610.42-0.060.290.240.110.320.990.630.030.35-0.42-0.170.2-0.14-0.11
0.620.310.670.540.61-0.150.380.690.290.740.59-0.390.290.66-0.30.90.370.740.690.460.07-0.440.52-0.44-0.46
0.620.060.490.610.85-0.110.310.680.240.760.77-0.480.240.66-0.220.610.340.740.50.33-0.01-0.550.52-0.52-0.55
0.01-0.25-0.230.06-0.03-0.09-0.960.010.11-0.080.010.860.11-0.3-0.22-0.290.12-0.08-0.410.06-0.880.56-0.610.680.54
0.710.640.920.590.66-0.20.330.730.320.830.47-0.370.320.90.61-0.290.40.790.60.680.06-0.310.51-0.38-0.27
0.890.080.370.920.62-0.940.020.520.990.70.47-0.090.990.370.340.120.40.710.080.45-0.45-0.20.25-0.18-0.15
0.940.410.710.90.79-0.550.180.640.630.980.56-0.330.630.740.74-0.080.790.710.210.59-0.3-0.290.4-0.32-0.28
0.220.060.440.150.490.160.470.620.030.310.57-0.430.030.690.5-0.410.60.080.210.340.41-0.510.62-0.5-0.53
0.660.650.760.590.6-0.240.00.420.350.70.16-0.220.350.460.330.060.680.450.590.34-0.240.00.42-0.050.0
-0.380.090.05-0.43-0.230.40.83-0.12-0.42-0.27-0.14-0.66-0.420.07-0.01-0.880.06-0.45-0.30.41-0.24-0.430.47-0.48-0.42
-0.250.11-0.22-0.3-0.470.14-0.69-0.35-0.17-0.33-0.360.71-0.17-0.44-0.550.56-0.31-0.2-0.29-0.510.0-0.43-0.520.780.92
0.390.20.450.380.59-0.130.720.390.20.480.23-0.790.20.520.52-0.610.510.250.40.620.420.47-0.52-0.38-0.6
-0.29-0.06-0.27-0.27-0.390.08-0.69-0.35-0.14-0.35-0.430.68-0.14-0.44-0.520.68-0.38-0.18-0.32-0.5-0.05-0.480.78-0.380.77
-0.220.21-0.17-0.28-0.490.07-0.69-0.36-0.11-0.33-0.370.73-0.11-0.46-0.550.54-0.27-0.15-0.28-0.530.0-0.420.92-0.60.77
Click cells to compare fundamentals

Biodexa Pharmaceticals Account Relationship Matchups

Biodexa Pharmaceticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets30.9M9.8M12.9M5.5M10.5M20.9M
Other Current Liab761K2.4M1.2M1.3M5.0M5.3M
Total Current Liabilities5.7M3.0M1.8M1.9M5.6M3.8M
Total Stockholder Equity19.6M6.7M10.5M3.2M4.7M4.4M
Property Plant And Equipment Net2.2M542K1.2M831K571K542.5K
Net Debt(4.8M)(7.3M)(9.3M)(2.2M)(5.5M)(5.8M)
Retained Earnings(99.8M)(122.4M)(127.8M)(135.3M)(144.8M)(137.5M)
Accounts Payable4.5M337K485K339K314K298.3K
Cash10.9M7.5M10.1M2.8M6.0M8.0M
Non Current Assets Total17.2M542K1.2M837K3.5M3.3M
Non Currrent Assets Other2.6M(542K)(1.2M)(837K)(753.3K)(715.6K)
Cash And Short Term Investments10.9M7.5M10.1M2.8M6.0M8.0M
Non Current Liabilities Total5.7M110K619.5K463K295K280.3K
Other Current Assets2.8M258K607K376K355K337.3K
Other Stockholder Equity65.9M74.4M85.2M83.7M86.7M59.2M
Total Liab11.3M3.1M2.5M2.4M5.9M5.8M
Total Current Assets13.7M9.3M11.8M4.7M7.0M10.0M
Intangible Assets14.2M10.1M10.1M6K2.9M2.8M
Short Long Term Debt Total6.1M260K766K624K464K440.8K
Net Receivables22K95K33K329K704K455.7K
Liabilities And Stockholders Equity30.9M9.8M12.9M5.5M10.5M10.0M
Accumulated Other Comprehensive Income56.4M53.7M53.5M53.0M61.5M53.6M
Short Term Debt412K200K146K161K169K307.8K
Common Stock23K63K98.5K1.1M1.2M1.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodexa Stock Analysis

When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.